KBC Group NV Purchases 104,554 Shares of DaVita Inc. $DVA

KBC Group NV increased its holdings in shares of DaVita Inc. (NYSE:DVA) by 38.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 374,749 shares of the company’s stock after acquiring an additional 104,554 shares during the quarter. KBC Group NV owned approximately 0.52% of DaVita worth $53,383,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. National Pension Service raised its holdings in DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company’s stock valued at $30,000 after acquiring an additional 84 shares during the period. Hantz Financial Services Inc. grew its position in DaVita by 48.1% in the second quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock worth $33,000 after acquiring an additional 75 shares in the last quarter. Y.D. More Investments Ltd purchased a new position in shares of DaVita during the 1st quarter valued at about $35,000. Mid American Wealth Advisory Group Inc. bought a new position in shares of DaVita during the 2nd quarter valued at $36,000. Finally, Ameritas Advisory Services LLC bought a new stake in shares of DaVita in the 2nd quarter valued at about $47,000. Institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 1.0%

Shares of DaVita stock opened at $123.55 on Thursday. The firm’s 50 day simple moving average is $128.26 and its two-hundred day simple moving average is $135.63. DaVita Inc. has a 12-month low of $115.39 and a 12-month high of $179.60. The firm has a market capitalization of $8.72 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 0.91 and a beta of 1.13.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $2.51 earnings per share for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). The firm had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.43 billion. DaVita had a net margin of 5.80% and a return on equity of 815.62%. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.59 earnings per share. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. On average, sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a report on Wednesday, October 8th. TD Cowen cut their price objective on shares of DaVita from $154.00 to $133.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Truist Financial set a $140.00 price target on DaVita in a report on Tuesday, October 14th. Wall Street Zen cut DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Finally, Bank of America cut their target price on shares of DaVita from $145.00 to $140.00 and set an “underperform” rating for the company in a research report on Wednesday, September 10th. Five analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, DaVita has an average rating of “Reduce” and an average price target of $148.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.